Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 832

1.

A Case of Switching from GnRH Agonist to Antagonist for Castration Resistant Prostate Cancer Control.

Sugimura R, Kawahara T, Miyoshi Y, Yao M, Chiba S, Uemura H.

Case Rep Oncol. 2019 Sep 17;12(3):688-692. doi: 10.1159/000502859. eCollection 2019 Sep-Dec.

2.

Diagnostic feature of imaging for hernia through the foramen of Winslow.

Miyoshi Y, Hirano Y, Kondo Y, Note H, Takagi M, Takizawa S, Okamoto K, Tanaka H.

Acute Med Surg. 2019 Jun 12;6(4):423-424. doi: 10.1002/ams2.437. eCollection 2019 Oct. No abstract available.

3.

A Single-centre, Retrospective, Observational Analysis of Fulvestrant for Recurrent/metastatic Breast Cancer According to Metastatic Site.

Ozawa H, Sata A, Fukui R, Bun A, Higuchi T, Fujimoto Y, Miyagawa Y, Imamura M, Miyoshi Y.

Anticancer Res. 2019 Oct;39(10):5653-5662. doi: 10.21873/anticanres.13762.

PMID:
31570463
4.

Longer Control of Nivolumab in Metastatic Renal Cell Carcinoma Patients with End-Stage Kidney Disease on Dialysis.

Morinaga R, Kawahara T, Miyoshi Y, Yao M, Uemura H.

Case Rep Oncol. 2019 Aug 6;12(2):608-612. doi: 10.1159/000501768. eCollection 2019 May-Aug.

5.

Changing the Timing of Enzalutamide Intake from Morning to before Sleep at Night Overcame Enzalutamide-Induced Dysgeusia.

Kawahara T, Miyoshi Y, Yao M, Uemura H.

Case Rep Oncol. 2019 Aug 6;12(2):589-594. doi: 10.1159/000502054. eCollection 2019 May-Aug.

6.

Preference for enzalutamide capsules versus tablet pills in patients with prostate cancer.

Ninomiya S, Kawahara T, Tatenuma T, Miyoshi Y, Miyamoto H, Yao M, Uemura H.

Int J Urol. 2019 Sep 18. doi: 10.1111/iju.14101. [Epub ahead of print] No abstract available.

PMID:
31532007
7.

High Serum Levels of Interleukin-18 Are Associated With Worse Outcomes in Patients With Breast Cancer.

Inoue N, Li W, Fujimoto Y, Matsushita Y, Katagiri T, Okamura H, Miyoshi Y.

Anticancer Res. 2019 Sep;39(9):5009-5018. doi: 10.21873/anticanres.13691.

PMID:
31519608
8.

The association between bilateral maximum occlusal force and all-cause mortality among community-dwelling older adults: The Tsurugaya project.

Ohi T, Komiyama T, Miyoshi Y, Murakami T, Tsuboi A, Tomata Y, Tsuji I, Watanabe M, Hattori Y.

J Prosthodont Res. 2019 Sep 4. pii: S1883-1958(19)30055-6. doi: 10.1016/j.jpor.2019.08.005. [Epub ahead of print]

PMID:
31494054
9.

Significance of pre-hospital care to reduce the morbidity of eclampsia in rural Zambia.

Miyoshi Y, Matsubara K, Takata N, Oka Y.

Pregnancy Hypertens. 2019 Jul;17:100-103. doi: 10.1016/j.preghy.2019.05.008. Epub 2019 May 9.

PMID:
31487623
10.

Correlation between Automated Bone Scan Index Change after Cabazitaxel and Survival among Men with Castration-Resistant Prostate Cancer.

Miyoshi Y, Sakamoto S, Kawahara T, Uemura K, Yokomizo Y, Uemura H.

Urol Int. 2019;103(3):279-284. doi: 10.1159/000502655. Epub 2019 Aug 28.

PMID:
31461725
11.

Phase I trial of TAK-385 in hormone treatment-naïve Japanese patients with nonmetastatic prostate cancer.

Suzuki H, Uemura H, Mizokami A, Hayashi N, Miyoshi Y, Nagamori S, Enomoto Y, Akaza H, Asato T, Kitagawa T, Suzuki K.

Cancer Med. 2019 Oct;8(13):5891-5902. doi: 10.1002/cam4.2442. Epub 2019 Aug 19.

12.

The Achievement of Long-Term CRPC Control in a Patient with Enzalutamide-Induced Nausea and Fatigue after Overcoming the Adverse Events with a Temporary Drug Holiday.

Kawahara T, Miyoshi Y, Yao M, Uemura H.

Case Rep Oncol. 2019 Jul 16;12(2):568-572. doi: 10.1159/000501849. eCollection 2019 May-Aug.

13.

Inserting a Metallic Ureteral Stent Using an Antegrade Approach Freed a Patient from Nephrostomy Created due to Hydronephrosis Caused by Bladder Cancer.

Kawahara T, Takamoto D, Miyoshi Y, Yao M, Uemura H.

Case Rep Oncol. 2019 Jul 16;12(2):560-563. doi: 10.1159/000501767. eCollection 2019 May-Aug.

14.

Successful Resection of Cisplatin-Resistant Renal Pelvic Cancer after the Administration of Pembrolizumab as Second-Line Therapy.

Kawahara T, Mochizuki T, Sugimura R, Izumi K, Kuroda S, Miyoshi Y, Nakaigawa N, Yao M, Tanabe M, Uemura H.

Case Rep Oncol. 2019 Jul 16;12(2):548-553. doi: 10.1159/000501715. eCollection 2019 May-Aug.

15.

Long-Term Control of Metastatic Renal Cell Carcinoma Using Pazopanib.

Kawahara T, Takeshima T, Miyoshi Y, Nakaigawa N, Yao M, Tanabe M, Uemura H.

Case Rep Oncol. 2019 Jul 16;12(2):543-547. doi: 10.1159/000501716. eCollection 2019 May-Aug.

16.

Effects of Zinc Acetate on Serum Zinc Concentrations in Chronic Liver Diseases: a Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial and a Dose Adjustment Trial.

Katayama K, Hosui A, Sakai Y, Itou M, Matsuzaki Y, Takamori Y, Hosho K, Tsuru T, Takikawa Y, Michitaka K, Ogawa E, Miyoshi Y, Ito T, Ida S, Hamada I, Miyoshi K, Kodama H, Takehara T.

Biol Trace Elem Res. 2019 Aug 7. doi: 10.1007/s12011-019-01851-y. [Epub ahead of print]

PMID:
31392541
17.

Restorative yoga for occupational stress among Japanese female nurses working night shift: Randomized crossover trial.

Miyoshi Y.

J Occup Health. 2019 Jul 31. doi: 10.1002/1348-9585.12080. [Epub ahead of print]

18.

Liberal versus restrictive red blood cell transfusion strategy in sepsis or septic shock: a systematic review and meta-analysis of randomized trials.

Hirano Y, Miyoshi Y, Kondo Y, Okamoto K, Tanaka H.

Crit Care. 2019 Jul 25;23(1):262. doi: 10.1186/s13054-019-2543-1.

19.

On-line rapid purification of [13N]N2 gas for visualization of nitrogen fixation and translocation in nodulated soybean.

Yin YG, Ishii S, Suzui N, Igura M, Kurita K, Miyoshi Y, Nagasawa N, Taguchi M, Kawachi N.

Appl Radiat Isot. 2019 Sep;151:7-12. doi: 10.1016/j.apradiso.2019.05.034. Epub 2019 May 28.

PMID:
31151049
20.

Present status of prophylactic thyroidectomy in pediatric multiple endocrine neoplasia 2: a nationwide survey in Japan 1997-2017.

Matsushita R, Nagasaki K, Ayabe T, Miyoshi Y, Kinjo S, Haruna H, Ihara K, Hasegawa T, Ida S, Ozono K, Minamitani K; Thyroid Committee of the Japanese Society for Pediatric Endocrinology.

J Pediatr Endocrinol Metab. 2019 Jun 26;32(6):585-595. doi: 10.1515/jpem-2018-0444.

PMID:
31150358
21.

Participants in a randomized controlled trial had longer overall survival than non-participants: a prospective cohort study.

Ohno S, Mukai H, Narui K, Hozumi Y, Miyoshi Y, Yoshino H, Doihara H, Suto A, Tamura M, Morimoto T, Zaha H, Chishima T, Nishimura R, Ishikawa T, Uemura Y, Ohashi Y.

Breast Cancer Res Treat. 2019 Aug;176(3):631-635. doi: 10.1007/s10549-019-05276-y. Epub 2019 May 21.

PMID:
31115845
22.

Prognostic significance of tumor-infiltrating lymphocytes may differ depending on Ki67 expression levels in estrogen receptor-positive/HER2-negative operated breast cancers.

Fujimoto Y, Watanabe T, Hida AI, Higuchi T, Miyagawa Y, Ozawa H, Bun A, Fukui R, Sata A, Imamura M, Hirota S, Miyoshi Y.

Breast Cancer. 2019 May 16. doi: 10.1007/s12282-019-00977-0. [Epub ahead of print]

PMID:
31098866
23.

Factors associated with treatment delay in women with primary breast cancer who were referred to reproductive specialists.

Kitano A, Shimizu C, Yamauchi H, Akitani F, Shiota K, Miyoshi Y, Ohde S.

ESMO Open. 2019 Mar 5;4(2):e000459. doi: 10.1136/esmoopen-2018-000459. eCollection 2019.

24.

Androgen receptor mRNA expression is a predictor for recurrence-free survival in non-muscle invasive bladder cancer.

Yasui M, Kawahara T, Izumi K, Yao M, Ishiguro Y, Ishiguro H, Uemura H, Miyoshi Y.

BMC Cancer. 2019 Apr 8;19(1):331. doi: 10.1186/s12885-019-5512-9.

25.

Significance of Metabolic Tumor Volume at Baseline and Reduction of Mean Standardized Uptake Value in 18F-FDG-PET/CT Imaging for Predicting Pathological Complete Response in Breast Cancers Treated with Preoperative Chemotherapy.

Higuchi T, Fujimoto Y, Ozawa H, Bun A, Fukui R, Miyagawa Y, Imamura M, Kitajima K, Yamakado K, Miyoshi Y.

Ann Surg Oncol. 2019 Jul;26(7):2175-2183. doi: 10.1245/s10434-019-07325-8. Epub 2019 Apr 2.

26.

Early assessment with 18F-2-fluoro-2-deoxyglucose positron emission tomography/computed tomography to predict short-term outcome in clear cell renal carcinoma treated with nivolumab.

Tabei T, Nakaigawa N, Kaneta T, Ikeda I, Kondo K, Makiyama K, Hasumi H, Hayashi N, Kawahara T, Izumi K, Osaka K, Muraoka K, Teranishi JI, Miyoshi Y, Yumura Y, Uemura H, Kobayashi K, Inoue T, Yao M.

BMC Cancer. 2019 Apr 2;19(1):298. doi: 10.1186/s12885-019-5510-y.

27.

Maximum Occlusal Force and Incident Functional Disability in Older Adults: The Tsurugaya Project.

Ohi T, Komiyama T, Miyoshi Y, Murakami T, Tsuboi A, Tomata Y, Tsuji I, Watanabe M, Hattori Y.

JDR Clin Trans Res. 2018 Apr;3(2):195-202. doi: 10.1177/2380084418761329. Epub 2018 Feb 26.

PMID:
30931768
28.

The Space Physics Environment Data Analysis System (SPEDAS).

Angelopoulos V, Cruce P, Drozdov A, Grimes EW, Hatzigeorgiu N, King DA, Larson D, Lewis JW, McTiernan JM, Roberts DA, Russell CL, Hori T, Kasahara Y, Kumamoto A, Matsuoka A, Miyashita Y, Miyoshi Y, Shinohara I, Teramoto M, Faden JB, Halford AJ, McCarthy M, Millan RM, Sample JG, Smith DM, Woodger LA, Masson A, Narock AA, Asamura K, Chang TF, Chiang CY, Kazama Y, Keika K, Matsuda S, Segawa T, Seki K, Shoji M, Tam SWY, Umemura N, Wang BJ, Wang SY, Redmon R, Rodriguez JV, Singer HJ, Vandegriff J, Abe S, Nose M, Shinbori A, Tanaka YM, UeNo S, Andersson L, Dunn P, Fowler C, Halekas JS, Hara T, Harada Y, Lee CO, Lillis R, Mitchell DL, Argall MR, Bromund K, Burch JL, Cohen IJ, Galloy M, Giles B, Jaynes AN, Le Contel O, Oka M, Phan TD, Walsh BM, Westlake J, Wilder FD, Bale SD, Livi R, Pulupa M, Whittlesey P, DeWolfe A, Harter B, Lucas E, Auster U, Bonnell JW, Cully CM, Donovan E, Ergun RE, Frey HU, Jackel B, Keiling A, Korth H, McFadden JP, Nishimura Y, Plaschke F, Robert P, Turner DL, Weygand JM, Candey RM, Johnson RC, Kovalick T, Liu MH, McGuire RE, Breneman A, Kersten K, Schroeder P.

Space Sci Rev. 2019;215(1):9. doi: 10.1007/s11214-018-0576-4. Epub 2019 Jan 22. Review.

29.

Baby survival in Zambia: stillbirth and neonatal death in a local hospital setting.

Miyoshi Y, Matsubara K, Takata N, Oka Y.

BMC Pregnancy Childbirth. 2019 Mar 12;19(1):90. doi: 10.1186/s12884-019-2231-9.

30.

Prognostic value of 18F-FDG PET/CT prior to breast cancer treatment. Comparison with magnetic resonance spectroscopy and diffusion weighted imaging.

Kitajima K, Yamano T, Miyoshi Y, Katsuura T, Enoki T, Yamakado K.

Hell J Nucl Med. 2019 Jan-Apr;22(1):25-35. doi: 10.1967/s002449910956. Epub 2019 Mar 7.

PMID:
30843007
31.

Pretreatment Neutrophil to Lymphocyte Ratio (NLR) Predicts Prognosis for Castration Resistant Prostate Cancer Patients Underwent Enzalutamide.

Kumano Y, Hasegawa Y, Kawahara T, Yasui M, Miyoshi Y, Matsubara N, Uemura H.

Biomed Res Int. 2019 Jan 20;2019:9450838. doi: 10.1155/2019/9450838. eCollection 2019.

32.

Influences of Total Laparoscopic Hysterectomy According to Body Mass Index (Underweight, Normal Weight, Overweight, or Obese).

Otake A, Horai M, Tanaka E, Toda A, Miyoshi Y, Funada R, Yamamoto Y, Adachi K.

Gynecol Minim Invasive Ther. 2019 Jan-Mar;8(1):19-24. doi: 10.4103/GMIT.GMIT_53_18. Epub 2019 Jan 23.

33.

Significance of baseline neutrophil-to-lymphocyte ratio for progression-free survival of patients with HER2-positive breast cancer treated with trastuzumab emtansine.

Imamura M, Morimoto T, Egawa C, Fukui R, Bun A, Ozawa H, Miyagawa Y, Fujimoto Y, Higuchi T, Miyoshi Y.

Sci Rep. 2019 Feb 12;9(1):1811. doi: 10.1038/s41598-018-37633-0.

34.

IgA-enhancing effects of membrane vesicles derived from Lactobacillus sakei subsp. sakei NBRC15893.

Yamasaki-Yashiki S, Miyoshi Y, Nakayama T, Kunisawa J, Katakura Y.

Biosci Microbiota Food Health. 2019;38(1):23-29. doi: 10.12938/bmfh.18-015. Epub 2018 Nov 1.

35.

In-stem molecular beacon targeted to a 5'-region of tRNA inclusive of the D arm that detects mature tRNA with high sensitivity.

Miyoshi Y, Ohtsuki T, Kashida H, Asanuma H, Watanabe K.

PLoS One. 2019 Jan 29;14(1):e0211505. doi: 10.1371/journal.pone.0211505. eCollection 2019.

36.

Dynamic Analysis of Photosynthate Translocation Into Strawberry Fruits Using Non-invasive 11C-Labeling Supported With Conventional Destructive Measurements Using 13C-Labeling.

Hidaka K, Miyoshi Y, Ishii S, Suzui N, Yin YG, Kurita K, Nagao K, Araki T, Yasutake D, Kitano M, Kawachi N.

Front Plant Sci. 2019 Jan 9;9:1946. doi: 10.3389/fpls.2018.01946. eCollection 2018.

37.

Improved prognosis of low baseline neutrophil-to-lymphocyte ratio is significantly exclusive in breast cancer patients with high absolute counts of lymphocytes.

Fujimoto Y, Ozawa H, Higuchi T, Miyagawa Y, Bun A, Imamura M, Miyoshi Y.

Mol Clin Oncol. 2019 Feb;10(2):275-284. doi: 10.3892/mco.2018.1783. Epub 2018 Dec 4.

38.

Associations in tumor infiltrating lymphocytes between clinicopathological factors and clinical outcomes in estrogen receptor-positive/human epidermal growth factor receptor type 2 negative breast cancer.

Miyoshi Y, Shien T, Ogiya A, Ishida N, Yamazaki K, Horii R, Horimoto Y, Masuda N, Yasojima H, Inao T, Osako T, Takahashi M, Tomioka N, Wanifuchi-Endo Y, Hosoda M, Doihara H, Yamashita H.

Oncol Lett. 2019 Feb;17(2):2177-2186. doi: 10.3892/ol.2018.9853. Epub 2018 Dec 19.

39.

Visualization of rapid electron precipitation via chorus element wave-particle interactions.

Ozaki M, Miyoshi Y, Shiokawa K, Hosokawa K, Oyama SI, Kataoka R, Ebihara Y, Ogawa Y, Kasahara Y, Yagitani S, Kasaba Y, Kumamoto A, Tsuchiya F, Matsuda S, Katoh Y, Hikishima M, Kurita S, Otsuka Y, Moore RC, Tanaka Y, Nosé M, Nagatsuma T, Nishitani N, Kadokura A, Connors M, Inoue T, Matsuoka A, Shinohara I.

Nat Commun. 2019 Jan 16;10(1):257. doi: 10.1038/s41467-018-07996-z.

40.

Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancer.

Johmura Y, Maeda I, Suzuki N, Wu W, Goda A, Morita M, Yamaguchi K, Yamamoto M, Nagasawa S, Kojima Y, Tsugawa K, Inoue N, Miyoshi Y, Osako T, Akiyama F, Maruyama R, Inoue JI, Furukawa Y, Ohta T, Nakanishi M.

J Clin Invest. 2018 Dec 3;128(12):5603-5619. doi: 10.1172/JCI121679. Epub 2018 Nov 12.

41.

PD-1 and PD-L1 are more highly expressed in high-grade bladder cancer than in low-grade cases: PD-L1 might function as a mediator of stage progression in bladder cancer.

Kawahara T, Ishiguro Y, Ohtake S, Kato I, Ito Y, Ito H, Makiyama K, Kondo K, Miyoshi Y, Yumura Y, Hayashi N, Hasumi H, Osaka K, Muraoka K, Izumi K, Teranishi JI, Uemura H, Yao M, Nakaigawa N.

BMC Urol. 2018 Nov 6;18(1):97. doi: 10.1186/s12894-018-0414-8.

42.

Predictive impact of absolute lymphocyte counts for progression-free survival in human epidermal growth factor receptor 2-positive advanced breast cancer treated with pertuzumab and trastuzumab plus eribulin or nab-paclitaxel.

Araki K, Ito Y, Fukada I, Kobayashi K, Miyagawa Y, Imamura M, Kira A, Takatsuka Y, Egawa C, Suwa H, Ohno S, Miyoshi Y.

BMC Cancer. 2018 Oct 16;18(1):982. doi: 10.1186/s12885-018-4888-2.

43.

Prediction of Time to Castration-Resistant Prostate Cancer Using Low-Molecular-Weight Protein Tyrosine Phosphatase Expression for Men with Metastatic Hormone-Naïve Prostate Cancer.

Miyoshi Y, Ohtaka M, Kawahara T, Ohtake S, Yasui M, Uemura K, Yoneyama S, Yokomizo Y, Uemura H, Miyamoto H, Yao M.

Urol Int. 2019;102(1):37-42. doi: 10.1159/000493324. Epub 2018 Oct 16.

PMID:
30326476
44.

Sporadic case of Darier disease caused by a novel splice-site mutation in the ATP2A2 gene.

Yasuno S, Miyoshi Y, Asano N, Okita T, Yamaguchi M, Shimomura N, Kashiwagi K, Shimomura Y.

Clin Exp Dermatol. 2019 Mar;44(2):e10-e12. doi: 10.1111/ced.13806. Epub 2018 Oct 7. No abstract available.

PMID:
30294936
45.

HERC2 Facilitates BLM and WRN Helicase Complex Interaction with RPA to Suppress G-Quadruplex DNA.

Wu W, Rokutanda N, Takeuchi J, Lai Y, Maruyama R, Togashi Y, Nishikawa H, Arai N, Miyoshi Y, Suzuki N, Saeki Y, Tanaka K, Ohta T.

Cancer Res. 2018 Nov 15;78(22):6371-6385. doi: 10.1158/0008-5472.CAN-18-1877. Epub 2018 Oct 2.

PMID:
30279242
46.

C-reactive Protein Level on Postoperative Day One is Associated with Chronic Postsurgical Pain After Mastectomy.

Hashimoto K, Tsuji A, Takenaka S, Ohmura A, Ueki R, Noma H, Imamura M, Miyoshi Y, Kariya N, Tatara T, Hirose M.

Anesth Pain Med. 2018 Aug 7;8(4):e79331. doi: 10.5812/aapm.79331. eCollection 2018 Aug.

47.

Direct measurements of two-way wave-particle energy transfer in a collisionless space plasma.

Kitamura N, Kitahara M, Shoji M, Miyoshi Y, Hasegawa H, Nakamura S, Katoh Y, Saito Y, Yokota S, Gershman DJ, Vinas AF, Giles BL, Moore TE, Paterson WR, Pollock CJ, Russell CT, Strangeway RJ, Fuselier SA, Burch JL.

Science. 2018 Sep 7;361(6406):1000-1003. doi: 10.1126/science.aap8730.

PMID:
30190400
48.

CYP7A1 expression in hepatocytes is retained with upregulated fibroblast growth factor 19 in pediatric biliary atresia.

Hasegawa Y, Kawai M, Bessho K, Yasuda K, Ueno T, Satomura Y, Konishi A, Kimura T, Ikeda K, Tachibana M, Miyoshi Y, Michigami T, Kondou H, Ozono K.

Hepatol Res. 2019 Mar;49(3):314-323. doi: 10.1111/hepr.13245. Epub 2018 Oct 3.

PMID:
30156739
49.

Association between tooth loss and cognitive impairment in community-dwelling older Japanese adults: a 4-year prospective cohort study from the Ohasama study.

Saito S, Ohi T, Murakami T, Komiyama T, Miyoshi Y, Endo K, Satoh M, Asayama K, Inoue R, Kikuya M, Metoki H, Imai Y, Ohkubo T, Hattori Y.

BMC Oral Health. 2018 Aug 20;18(1):142. doi: 10.1186/s12903-018-0602-7.

50.

High levels of serum CA15-3 and residual invasive tumor size are associated with poor prognosis for breast cancer patients with non-pathological complete response after neoadjuvant chemotherapy.

Fujimoto Y, Higuchi T, Nishimukai A, Miyagawa Y, Kira A, Ozawa H, Bun A, Imamura M, Miyoshi Y.

J Surg Oncol. 2018 Jul;118(1):228-237. doi: 10.1002/jso.25125. Epub 2018 Jun 24.

PMID:
29936704

Supplemental Content

Loading ...
Support Center